ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,0874
-0,19%
Bitcoin
66.657,12
-0,42%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Vyant Bio Inc (VYNT)

  7. Vyant Bio Inc (VYNT) News

VYNT

Vyant Bio (VYNT)

Vyant Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VYNT
DatumZeitQuelleÜberschriftSymbolFirma
26/12/202315h15GlobeNewswire Inc.Vyant Bio Provides Update on Winddown ActivitiesNASDAQ:VYNTVyant Bio Inc
10/11/202322h05GlobeNewswire Inc.Vyant Bio Provides Update on Winddown ActivitiesNASDAQ:VYNTVyant Bio Inc
01/11/202316h45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Plan of DissolutionNASDAQ:VYNTVyant Bio Inc
24/10/202322h00GlobeNewswire Inc.Vyant Bio Announces Completion of StemoniX Asset SaleNASDAQ:VYNTVyant Bio Inc
19/10/202317h45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
11/10/202317h45GlobeNewswire Inc.Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
28/09/202317h45GlobeNewswire Inc.Vyant Bio Announces Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
20/09/202319h00GlobeNewswire Inc.Vyant Bio Announces Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
31/07/202323h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VYNTVyant Bio Inc
15/05/202314h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VYNTVyant Bio Inc
12/05/202314h00GlobeNewswire Inc.Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
10/05/202314h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNTVyant Bio Inc
04/05/202322h33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:VYNTVyant Bio Inc
04/05/202322h30GlobeNewswire Inc.Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
24/04/202322h50GlobeNewswire Inc.Vyant Bio Announces Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
28/03/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
28/03/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
28/03/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
28/03/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
28/03/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
28/03/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
24/03/202314h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNTVyant Bio Inc
24/03/202314h05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202314h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313h56Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313h53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313h49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313h44Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313h35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VYNTVyant Bio Inc
24/03/202313h28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VYNTVyant Bio Inc
 Showing the most relevant articles for your search:NASDAQ:VYNT

Kürzlich von Ihnen besucht

NASDAQ
HSPOR
Horizon Space Acquisitio...
BIT
UB87NQ
Unicredit Bank
NASDAQ
DARAD
COIN
NMTGBP
NASDAQI
CX20GI
OMX Copenhagen Health Ca...
EU
FXGD
FinEx Gold ETF
AMEX
RYDE
Ryde
AMEX
FTBD
Fidelity Tactical Bond ETF
UNSW
DEXETH
AlphaDex
BIT
UB2Y68
UniCredit Bank
COIN
PERPGBP
Perpetual
BIT
UC8YK7
Unicredit Bank
COIN
NASTETH
BIT
UC92RT
Unicredit Bank
COIN
CRUIZEEUR
EU
7759T
7759T
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten